1. Home
  2. MEDP

MEDP

Medpace Holdings Inc.

Logo Medpace Holdings Inc.

Health Care

Biotechnology: Commercial Physical & Biological Resarch

Nasdaq

as 04-17-2024 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.

Founded: 1992 Country:
United States
United States
Employees: N/A City: CINCINNATI
Market Cap: 12.0B IPO Year: 2016
Target Price: $389.00 AVG Volume (30 days): 252.6K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 8.88 EPS Growth: 21.98
52 Week Low/High: $185.43 - $419.42 Next Earning Date: 04-22-2024
Revenue: $1,885,842,000 Revenue Growth: 29.17%
Revenue Growth (this year): 18.2% Revenue Growth (next year): 16.29%

Share on Social Networks: